MedTrace Logo

Clinical Trial to Assess the Influenza Vaccination (FLUVAC 02)

NCT01764152 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2025-09-02

No results posted yet for this study

Summary

This study assesses the seasonal of influenza vaccine effectiveness in adults hospitalised with laboratory-confirmed influenza through a network of hospitals in France

Conditions

  • Adult Hospitalized

Interventions

OTHER

nasopharyngeal sample

The nasopharyngeal sample will be used to find the types and subtypes of influenza virus and other respiratory viruses.

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Odile Launay, PU-PH · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-04-30
Completion
2013-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01764152 on ClinicalTrials.gov